vs

Side-by-side financial comparison of BRUKER CORP (BRKR) and ILLUMINA, INC. (ILMN). Click either name above to swap in a different company.

ILLUMINA, INC. is the larger business by last-quarter revenue ($1.1B vs $977.2M, roughly 1.1× BRUKER CORP). ILLUMINA, INC. runs the higher net margin — 16.8% vs 2.7%, a 14.2% gap on every dollar of revenue. On growth, BRUKER CORP posted the faster year-over-year revenue change (-0.2% vs -1.6%). ILLUMINA, INC. produced more free cash flow last quarter ($335.0M vs $207.2M). Over the past eight quarters, BRUKER CORP's revenue compounded faster (16.4% CAGR vs 0.8%).

Bruker Corporation is an American manufacturer of scientific instruments for molecular and materials research, as well as for industrial and applied analysis. It is headquartered in Billerica, Massachusetts, and is the publicly traded parent company of Bruker Scientific Instruments and Bruker Energy & Supercon Technologies (BEST) divisions.

Illumina, Inc. is an American biotechnology company, headquartered in San Diego, California. Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company provides a line of products and services that serves the sequencing, genotyping and gene expression, and proteomics markets, and serves more than 155 countries.

BRKR vs ILMN — Head-to-Head

Bigger by revenue
ILMN
ILMN
1.1× larger
ILMN
$1.1B
$977.2M
BRKR
Growing faster (revenue YoY)
BRKR
BRKR
+1.4% gap
BRKR
-0.2%
-1.6%
ILMN
Higher net margin
ILMN
ILMN
14.2% more per $
ILMN
16.8%
2.7%
BRKR
More free cash flow
ILMN
ILMN
$127.8M more FCF
ILMN
$335.0M
$207.2M
BRKR
Faster 2-yr revenue CAGR
BRKR
BRKR
Annualised
BRKR
16.4%
0.8%
ILMN

Income Statement — Q4 2025 vs Q4 2025

Metric
BRKR
BRKR
ILMN
ILMN
Revenue
$977.2M
$1.1B
Net Profit
$26.0M
$186.0M
Gross Margin
46.0%
65.9%
Operating Margin
7.8%
15.8%
Net Margin
2.7%
16.8%
Revenue YoY
-0.2%
-1.6%
Net Profit YoY
89.8%
205.7%
EPS (diluted)
$0.10
$1.16

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BRKR
BRKR
ILMN
ILMN
Q4 25
$977.2M
Q3 25
$860.5M
Q2 25
$797.4M
Q1 25
$801.4M
Q4 24
$979.6M
$1.1B
Q3 24
$864.4M
$1.1B
Q2 24
$800.7M
$1.1B
Q1 24
$721.7M
$1.1B
Net Profit
BRKR
BRKR
ILMN
ILMN
Q4 25
$26.0M
Q3 25
$-59.6M
Q2 25
$7.6M
Q1 25
$17.4M
Q4 24
$13.7M
$186.0M
Q3 24
$40.9M
$705.0M
Q2 24
$7.6M
$-2.0B
Q1 24
$50.9M
$-126.0M
Gross Margin
BRKR
BRKR
ILMN
ILMN
Q4 25
46.0%
Q3 25
44.1%
Q2 25
44.9%
Q1 25
48.8%
Q4 24
50.4%
65.9%
Q3 24
48.4%
69.0%
Q2 24
48.0%
64.8%
Q1 24
48.9%
62.0%
Operating Margin
BRKR
BRKR
ILMN
ILMN
Q4 25
7.8%
Q3 25
-6.0%
Q2 25
1.5%
Q1 25
4.0%
Q4 24
7.4%
15.8%
Q3 24
7.9%
68.6%
Q2 24
6.0%
-147.2%
Q1 24
9.0%
-10.3%
Net Margin
BRKR
BRKR
ILMN
ILMN
Q4 25
2.7%
Q3 25
-6.9%
Q2 25
1.0%
Q1 25
2.2%
Q4 24
1.4%
16.8%
Q3 24
4.7%
65.3%
Q2 24
0.9%
-178.8%
Q1 24
7.1%
-11.7%
EPS (diluted)
BRKR
BRKR
ILMN
ILMN
Q4 25
$0.10
Q3 25
$-0.41
Q2 25
$0.05
Q1 25
$0.11
Q4 24
$0.09
$1.16
Q3 24
$0.27
$4.42
Q2 24
$0.05
$-12.48
Q1 24
$0.35
$-0.79

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BRKR
BRKR
ILMN
ILMN
Cash + ST InvestmentsLiquidity on hand
$298.8M
$93.0M
Total DebtLower is stronger
$1.9B
Stockholders' EquityBook value
$2.5B
$2.4B
Total Assets
$6.2B
$6.3B
Debt / EquityLower = less leverage
0.76×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BRKR
BRKR
ILMN
ILMN
Q4 25
$298.8M
Q3 25
$293.1M
Q2 25
$92.0M
Q1 25
$184.2M
Q4 24
$183.4M
$93.0M
Q3 24
$148.1M
$70.0M
Q2 24
$169.7M
$74.0M
Q1 24
$340.1M
Total Debt
BRKR
BRKR
ILMN
ILMN
Q4 25
$1.9B
Q3 25
$2.0B
Q2 25
$2.4B
Q1 25
$2.1B
Q4 24
$2.1B
Q3 24
$2.3B
Q2 24
$2.2B
Q1 24
$1.4B
Stockholders' Equity
BRKR
BRKR
ILMN
ILMN
Q4 25
$2.5B
Q3 25
$2.4B
Q2 25
$1.8B
Q1 25
$1.8B
Q4 24
$1.8B
$2.4B
Q3 24
$1.8B
$2.1B
Q2 24
$1.8B
$1.4B
Q1 24
$1.4B
$5.7B
Total Assets
BRKR
BRKR
ILMN
ILMN
Q4 25
$6.2B
Q3 25
$6.4B
Q2 25
$6.3B
Q1 25
$5.9B
Q4 24
$5.8B
$6.3B
Q3 24
$6.1B
$6.0B
Q2 24
$5.9B
$6.1B
Q1 24
$4.5B
$10.0B
Debt / Equity
BRKR
BRKR
ILMN
ILMN
Q4 25
0.76×
Q3 25
0.83×
Q2 25
1.34×
Q1 25
1.15×
Q4 24
1.18×
Q3 24
1.27×
Q2 24
1.21×
Q1 24
0.97×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BRKR
BRKR
ILMN
ILMN
Operating Cash FlowLast quarter
$229.8M
$364.0M
Free Cash FlowOCF − Capex
$207.2M
$335.0M
FCF MarginFCF / Revenue
21.2%
30.3%
Capex IntensityCapex / Revenue
2.3%
2.6%
Cash ConversionOCF / Net Profit
8.84×
1.96×
TTM Free Cash FlowTrailing 4 quarters
$43.3M
$709.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BRKR
BRKR
ILMN
ILMN
Q4 25
$229.8M
Q3 25
$-33.2M
Q2 25
$-127.5M
Q1 25
$65.0M
Q4 24
$190.0M
$364.0M
Q3 24
$38.4M
$316.0M
Q2 24
$1.1M
$80.0M
Q1 24
$21.8M
$77.0M
Free Cash Flow
BRKR
BRKR
ILMN
ILMN
Q4 25
$207.2M
Q3 25
$-54.1M
Q2 25
$-148.8M
Q1 25
$39.0M
Q4 24
$153.3M
$335.0M
Q3 24
$5.8M
$284.0M
Q2 24
$-23.5M
$49.0M
Q1 24
$400.0K
$41.0M
FCF Margin
BRKR
BRKR
ILMN
ILMN
Q4 25
21.2%
Q3 25
-6.3%
Q2 25
-18.7%
Q1 25
4.9%
Q4 24
15.6%
30.3%
Q3 24
0.7%
26.3%
Q2 24
-2.9%
4.4%
Q1 24
0.1%
3.8%
Capex Intensity
BRKR
BRKR
ILMN
ILMN
Q4 25
2.3%
Q3 25
2.4%
Q2 25
2.7%
Q1 25
3.2%
Q4 24
3.7%
2.6%
Q3 24
3.8%
3.0%
Q2 24
3.1%
2.8%
Q1 24
3.0%
3.3%
Cash Conversion
BRKR
BRKR
ILMN
ILMN
Q4 25
8.84×
Q3 25
Q2 25
-16.78×
Q1 25
3.74×
Q4 24
13.87×
1.96×
Q3 24
0.94×
0.45×
Q2 24
0.14×
Q1 24
0.43×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BRKR
BRKR

Bsi Nano$309.1M32%
Bsi Biospin$267.0M27%
Other$179.9M18%
Transferred Over Time$142.5M15%
Energy And Supercon Technologies$69.5M7%

ILMN
ILMN

Sequencing$1.0B91%
Microarray$101.0M9%
Investee$7.0M1%

Related Comparisons